Abstract
AbstractThe gradual atraumatic dilatation of required extent of cervix for obstetrical procedure, especially in termination of pregnancy is the essential phenomena before evacuation of first and late first trimester of pregnancy. The methods available now are associated with serious side effects, causing an increased morbidity. So our experience with the clinical trial of “ISAPTENT (DILEX‐C)” in 60 patients of first trimester abortion has been reported. The satisfactory, atraumatic dilatation of cervix was achieved in 92 per cent of the patients with an average of 16.66 mm. dilatation by using single Isaptent (DILEX‐C) 20 hours prior to termination of pregnancy. The dilatation was found to have no relations to the age, parity and gestational period of the patients. There was no damage to the cervix. The Vaginal flora remained Unaltered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
